NASDAQ:FONR - Fonar Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $22.31 -0.14 (-0.62 %) (As of 03/20/2019 04:00 PM ET)Previous Close$22.45Today's Range$22.04 - $22.4952-Week Range$19.63 - $30.10Volume9,400 shsAverage Volume15,820 shsMarket Capitalization$141.85 millionP/E Ratio7.60Dividend YieldN/ABeta0.84 ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email FONAR Corporation, together with its subsidiaries, operates as a magnetic resonance imaging (MRI) company primarily in the Unites States. It is involved in the research, development, production, and marketing of medical scanning equipment, which uses principles of MRI for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries. The company operates in two segments, Manufacturing and Servicing of Medical Equipment, and Management of Diagnostic Imaging Centers. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company markets its scanners to private diagnostic imaging centers and hospitals. It also provides non-medical management services, including development, administration, office space leasing, facilities, equipment, supplies, staffing, credentialing, accounting, billing and collection, assistance with compliance matters, and practice growth and marketing strategies development and implementation services, as well as engages in the training and supervision of non-medical personnel for diagnostic imaging facilities. The company also exports its products to the United Arab Emirates, Switzerland, Canada, England, Germany, and Puerto Rico. It owns and operates 4 diagnostic imaging facilities in Florida; and manages 26 MRI scanning facilities, including 19 facilities located in New York and 7 situated in Florida. The company was founded in 1978 and is based in Melville, New York. Receive FONR News and Ratings via Email Sign-up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:FONR Previous Symbol CUSIPN/A CIK355019 Webwww.fonar.com Phone631-694-2929Debt Debt-to-Equity RatioN/A Current Ratio6.33 Quick Ratio6.19Price-To-Earnings Trailing P/E Ratio7.60 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$81.52 million Price / Sales1.74 Cash Flow$3.7814 per share Price / Cash Flow5.90 Book Value$16.26 per share Price / Book1.37Profitability EPS (Most Recent Fiscal Year)N/A Net Income$21.23 million Net Margins22.55% Return on Equity18.40% Return on Assets16.18%Miscellaneous EmployeesN/A Outstanding Shares6,358,000Market Cap$141.85 million Next Earnings Date5/9/2019 (Estimated) OptionableNot Optionable Fonar (NASDAQ:FONR) Frequently Asked Questions What is Fonar's stock symbol? Fonar trades on the NASDAQ under the ticker symbol "FONR." How were Fonar's earnings last quarter? Fonar Co. (NASDAQ:FONR) issued its quarterly earnings results on Monday, February, 11th. The medical equipment provider reported $0.51 EPS for the quarter. The medical equipment provider had revenue of $21.23 million for the quarter. Fonar had a net margin of 22.55% and a return on equity of 18.40%. View Fonar's Earnings History. When is Fonar's next earnings date? Fonar is scheduled to release their next quarterly earnings announcement on Thursday, May 9th 2019. View Earnings Estimates for Fonar. Has Fonar been receiving favorable news coverage? News coverage about FONR stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Fonar earned a media sentiment score of -1.5 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an impact on the company's share price in the next several days. Who are some of Fonar's key competitors? Some companies that are related to Fonar include BioLife Solutions (BLFS), Rockwell Medical (RMTI), Semler Scientific (SMLR), Cutera (CUTR), Electrocore (ECOR), Helius Medical Technologies (HSDT), Zynex (ZYXI), BioSig Technologies (BSGM), Stereotaxis (STXS), Second Sight Medical Products (EYES), Edap Tms (EDAP), IRIDEX (IRIX), Soleno Therapeutics (SLNO), Viveve Medical (VIVE) and Digirad (DRAD). What other stocks do shareholders of Fonar own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fonar investors own include Gilead Sciences (GILD), Lannett (LCI), Bausch Health Companies (BHC), Jazz Pharmaceuticals (JAZZ), Thermo Fisher Scientific (TMO), Horizon Pharma (HZNP), Soleno Therapeutics (SLNO), Incyte (INCY), Exelixis (EXEL) and Seattle Genetics (SGEN). Who are Fonar's key executives? Fonar's management team includes the folowing people: Dr. Raymond V. Damadian, Chairman, Principal Financial Officer & Treasurer (Age 83)Mr. Timothy R. Damadian, CEO & Pres (Age 55)Mr. Luciano B. Bonanni, COO & Exec. VP (Age 64)Ms. Claudette J. V. Chan, Sec. & Director (Age 81)Mr. Daniel Culver, Director of Communications Who are Fonar's major shareholders? Fonar's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (5.53%), Dimensional Fund Advisors LP (4.91%), Dimensional Fund Advisors LP (4.91%), LSV Asset Management (4.50%), Northern Trust Corp (1.55%) and Geode Capital Management LLC (1.07%). Company insiders that own Fonar stock include Raymond V Damadian and Robert J Janoff. View Institutional Ownership Trends for Fonar. Which major investors are selling Fonar stock? FONR stock was sold by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC, New York State Common Retirement Fund, Bailard Inc., Acadian Asset Management LLC, LSV Asset Management, Two Sigma Investments LP, Mackay Shields LLC and Stanley Laman Group Ltd.. View Insider Buying and Selling for Fonar. Which major investors are buying Fonar stock? FONR stock was purchased by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Dimensional Fund Advisors LP, Brandywine Global Investment Management LLC, Bank of New York Mellon Corp, Martingale Asset Management L P, BlackRock Inc., Seizert Capital Partners LLC and Bessemer Group Inc.. View Insider Buying and Selling for Fonar. How do I buy shares of Fonar? Shares of FONR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Fonar's stock price today? One share of FONR stock can currently be purchased for approximately $22.31. How big of a company is Fonar? Fonar has a market capitalization of $141.85 million and generates $81.52 million in revenue each year. What is Fonar's official website? The official website for Fonar is http://www.fonar.com. How can I contact Fonar? Fonar's mailing address is 110 Marcus Drive, Melville NY, 11747. The medical equipment provider can be reached via phone at 631-694-2929 or via email at [email protected] MarketBeat Community Rating for Fonar (NASDAQ FONR)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 99 (Vote Outperform)Underperform Votes: 89 (Vote Underperform)Total Votes: 188MarketBeat's community ratings are surveys of what our community members think about Fonar and other stocks. Vote "Outperform" if you believe FONR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FONR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/20/2019 by MarketBeat.com StaffFeatured Article: What is a conference call?